|
Volumn 24, Issue 4, 2016, Pages 521-522
|
Metformin Activates AMPK through the Lysosomal Pathway
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
AXIN;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
LAMTOR1 PROTEIN;
MAMMALIAN TARGET OF RAPAMYCIN;
METFORMIN;
PROTEIN;
RAPTOR PROTEIN;
UNCLASSIFIED DRUG;
ANTIDIABETIC AGENT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CLINICAL TRIAL (TOPIC);
COMPLEX FORMATION;
CONCENTRATION PROCESS;
CONTROLLED STUDY;
CYTOSOL;
ENZYME ACTIVATION;
HUMAN;
HUMAN CELL;
IMMUNOFLUORESCENCE TEST;
IMMUNOPRECIPITATION;
IN VITRO STUDY;
KNOCKOUT MOUSE;
LETTER;
LIVER CELL;
LIVER DISEASE;
LIVER HOMOGENATE;
LYSOSOME;
MOUSE;
NONHUMAN;
NUTRIENT SUPPLY;
OXIDATIVE PHOSPHORYLATION;
PRIORITY JOURNAL;
PROTEIN DEPLETION;
PROTEIN FUNCTION;
PROTEIN INTERACTION;
SINGLE DRUG DOSE;
ANIMAL;
DRUG EFFECTS;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
SIGNAL TRANSDUCTION;
AMP-ACTIVATED PROTEIN KINASES;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
ENZYME ACTIVATION;
HEPATOCYTES;
HUMANS;
HYPOGLYCEMIC AGENTS;
LYSOSOMES;
METFORMIN;
SIGNAL TRANSDUCTION;
|
EID: 84992363334
PISSN: 15504131
EISSN: 19327420
Source Type: Journal
DOI: 10.1016/j.cmet.2016.09.003 Document Type: Letter |
Times cited : (213)
|
References (10)
|